We describe two HTLV-I virus carriers who have biopsy-proven Hashimoto's thyroiditis. The first patient, a 64-year-old female, has had goiter and hypothyroidism since the age of 56. The second patient, a 66-year-old male, developed hyperthyroidism and goiter at the age of 44, but at present he is hypothyroid. Both patients are positive for anti-thyroid antibodies and anti-HTLV-I virus antibody. Findings of the thyroid biopsy specimens were consistent with Hashimoto's thyroiditis. These data suggest that Hashimoto's thyroiditis develops in HTLV-I carriers who have no clinical evidence of HAM/TSP.
Introduction

HTLV-I virus infection, either in asymptomatic
carriers or in patients who have developed HTLV-I associated myelopathy (HAM/TSP) (1, 2), is not infre quently associated with a variety of chronic inflammatory disorders, mostly with autoimmune disease. We pre viously reported two HAM/TSP patients who also had Hashimoto's thyroiditis (3, 4) and suggested a possible role of HTLV-I virus infection in the pathogenesis of Hashimoto's thyroiditis. We report here two HTLV-I carriers who have no clinical evidence of HAM/TSP but developed biopsy proven Hashimoto's thyroiditis, and emphasize the re lationship between HTLV-I infection and Hashimoto's thyroiditis.
Case Reports
Case1
A 64-year-old female, born in Shimizu, Kochi Pre fecture, Japan, first noted weight loss and goiter at the age of 56. Initial evaluation showed hypothyroidism but treatment was not instituted. At the age of 63, she noted further enlargement of the thyroid and was diagnosed as having Hashimoto's thyroiditis. Replacement therapy was started with subsequent normalization of thyroid function and a decrease in the size of goiter. She was referred to this hospital because of the presence of anti-HTLV-I virus antibody in her serum. Her family history was unremarkable. She was well nourished. Her pulse rate was 84/min, and blood pressure was 146/90 mmHg. The thyroid gland was elastic, hard and enlarged: right lobe, 7.5 x 3.0cm; left lobe, 7.0 x 3.4cm. Her chest and abdomen were normal. Neurologic examination showed no abnormalities. The erythrocyte sedimentation rate was 20mm/hr. The hemoglobin content was 13.0 g/dl, the red blood cell count 390 x 104//4 the white blood cell count 4,000//il, and the platelet count 19 x 104//il. (normal, <l:100) . The level of thyroid stimulating antibody (TSAb) was 100% (normal, <145%), anti thyroglobulin antibody 19.9 ng/ml (normal, <40.0 ng/ml), and TBII 5.6% (normal, <15%). The serum anti HTLV-I antibody titer measured by a particle aggluti nation method was 1:512 (normal, <l:100). Western blot analysis revealed pl9 and p24 
Case2
A-66-year-old male, born in Naruto City, Tokushima Prefecture, Japan, suffered from palpitations and in creased sweating, and was found to have goiter and hyperthyroidism at the age of 44. Radioisotope therapy improved his symptoms and decreased the size of the thyroid. At the age of 58, hyperlipidemia was noted. At the age of 66, he was found to be positive for serum anti-HTLV-I antibody and was referred to our hospital. His family history was unremarkable. He had suffered a fracture of the right foot at the age of 41, and received a transfusion of 600ml of whole blood. His vital signs were normal. His thyroid was slightly enlarged, but no obvious nodules were noted. Neuro logical examination showed no abnormality. His hemoglobin was 16.1g/dl, red blood cell count 475 x 104//il, and white blood cell count 4,300/^1 with a normal differential, and his platelet count was 23.7 X 104/ jA. His lymphocyte subpopulations consisted of 76.6% CD3(+), 40.3% CD4(+), and 36.4% CD8(+) with a CD4/CD8 ratio of 1.10. His serum cholesterol level was 208mg/dl, triglyceride level 87mg/dl and glucose level 87-mg/dl. Serum protein and immunoglobulin levels were normal. His serum TSH level was 6.97 /iU/ml, T4 8.5 //g/dl, T3 1.17ng/ml, free T4 0.78ng/dl, and free T3 3.47pg/ml. A thyroid test gave a value of 1:100, and a microsome test a value of 1:200. No TSAb, TBII, or antibodies against T3 and T4 were detected. Ultrasono graphy of the thyroid revealed no apparent enlargement, but showed an irregular surface, non homogeneous echogenicity inside the gland, and a tiny hypoechogenic region. The CT and radioscintigram of the thyroid and results on 131I uptake by the thyroid were normal. The serum anti-HTLV-I antibody titer was 1:512. Western blot analysis revealed bands of pl9, p24, gp46, and p53. Lymphocyte blast formation was normal with PHA, Con-A, and PWM. A biopsy specimen of the right lobe of the thyroid revealed lymphoid follicles with a germinal center, epithelial cells with large nuclei and granular oxyphilic cytoplasm, degenerative follicles, fibrosis and lymphocyte infiltration into the interstitium (Fig. lb) . These lymphocytes were positive for L-26, MB-1, LN1, LN2, UCHL-2, CD3, CD4, CD8, andMT-1. from both patients revealed amplified PCR products of 119bp (Fig. 2) .
Discussion HTLV-I virus is not only the cause of human T cell leukemia/lymphoma, but is also etiologically related to the development of HAM/TSP (1, 2). Moreover, chronic inflammatory disorders such as chronic inflam matory arthropathy (6) and pulmonary alveolitis (7-9), and autoimmune disorders including uveitis (10, ll), Sjogren's syndrome (12), Harada's disease (13) 
